PerkinElmer
Translational-Enterprise_1920-x-400.jpg

Brochure

Translational Enterprise, Data Access for Informed Patient Stratification

Introduction

Data Access for Informed Patient Stratification

Successful clinical trials depend on better-informed patient stratification strategies. However, these strategies can be fraught with inefficiencies due to:

  • Data access
  • Ad hoc querying
  • Data aggregation
  • Repeatable analytics for cross-study biomarker analysis

Whitepaper Summary

Translational researchers need user-friendly applications to test their biomarker hypothesis. This white paper details how analytics in PerkinElmer Signals™ Translational are designed precisely to help scientists extract real actionable insights for their Biomarker Discovery projects through:

  • Repeatable and scalable advanced analytics
  • Prepare and share guided analytics protocols
  • Integrated cohort selection for patient stratification